FDA Approves First Targeted Treatment for Patients with Cholangiocarcinoma, a Cancer of Bile Ducts

SILVER SPRING, Md., April 17, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration granted accelerated approval to Pemazyre (pemigatinib), the first treatment approved for adults with certain types of previously treated, advanced cholangiocarcinoma. "This approval...

from PR Newswire: https://ift.tt/2RMCcl7